Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome
YA Barde, G Bilbe, R Deogracias, RR Kuhn… - US Patent …, 2016 - Google Patents
Jope et al., 2006, Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and
therapeutic interventions. Curr. Drug Targets. Nov. 2006: 7 (11): 1421-1434 found Dec. 17 …
therapeutic interventions. Curr. Drug Targets. Nov. 2006: 7 (11): 1421-1434 found Dec. 17 …